| Date Filed | Type | Description |
| 06/15/2023 |
4
| Lewis Tanya (Chief Dev. Op. Officer) has filed a Form 4 on Replimune Group, Inc.|
Txns:
| Sold 12,043 shares
@ $24.1, valued at
$290.2k
Sold 817 shares
@ $23.45, valued at
$19.2k
|
|
| 05/18/2023 |
4
| Lewis Tanya (Chief Dev. Op. Officer) has filed a Form 4 on Replimune Group, Inc.|
Txns:
| Sold 12,207 shares
@ $18.05, valued at
$220.3k
|
|
| 04/04/2023 |
4
| Lewis Tanya (Chief Dev. Op. Officer) has filed a Form 4 on Replimune Group, Inc.|
Txns:
| Granted 40,000 shares
@ $0
Granted 60,000 options to buy
@ $17.66, valued at
$1.1M
|
|
| 03/06/2023 |
4
| Lewis Tanya (Director) has filed a Form 4 on DiaMedica Therapeutics Inc.|
Txns:
| Granted 26,443 options to buy
@ $1.77, valued at
$46.8k
|
|
| 03/06/2023 |
3
| Lewis Tanya (Director) has filed a Form 3 on DiaMedica Therapeutics Inc. |
| 05/18/2022 |
4
| Lewis Tanya (Chief Dev. Op Officer) has filed a Form 4 on Replimune Group, Inc.|
Txns:
| Sold 5,473 shares
@ $14.59, valued at
$79.9k
|
|
| 04/05/2022 |
4
| Lewis Tanya (Chief Dev.Op Off) has filed a Form 4 on Replimune Group, Inc.|
Txns:
| Granted 52,500 shares
@ $0
Granted 78,750 options to buy
@ $18.26, valued at
$1.4M
|
|
| 05/11/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 04/05/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 03/01/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/17/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/09/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 11/04/2020 |
4
| Lewis Tanya (EVP,Chief Reg.&Quality Officer) has filed a Form 4 on Karyopharm Therapeutics Inc.|
Txns:
| Sold 226 shares
@ $15.58, valued at
$3.5k
Exercised 765 restricted stock units
@ $0 |
|
| 11/03/2020 |
4
| Lewis Tanya (Director) has filed a Form 4 on Replimune Group, Inc.|
Txns:
| Granted 33,000 options to buy
@ $42, valued at
$1.4M
|
|
| 11/03/2020 |
3
| Lewis Tanya (Director) has filed a Form 3 on Replimune Group, Inc. |
| 02/07/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 11/05/2019 |
3
| Form 3 - Initial statement of beneficial ownership of securities: |
| 12/12/2008 |
4
| Lewis Tanya (VP Regulatory and Quality) has filed a Form 4 on VION PHARMACEUTICALS INC|
Txns:
| Granted 20,000 shares
@ $0 |
|
| 12/04/2008 |
3
| Lewis Tanya (Vice President, Regulatory) has filed a Form 3 on VION PHARMACEUTICALS INC |